125 related articles for article (PubMed ID: 37377029)
1. Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland.
Nikulainen I; Salminen AP; Seikkula H; Högerman M; Perez IM; Koskinen I; Sairanen J; Nikkola J; Murtola TJ; Vaarala MH; Jousmäki S; Nykopp TK; Isotalo T; Marttila T; Alibeto A; Seppänen M; Palmberg C; Boström PJ
Acta Oncol; 2023 Aug; 62(8):829-835. PubMed ID: 37377029
[TBL] [Abstract][Full Text] [Related]
2. Robotic and laparoscopic radical cystectomy for bladder cancer: long-term oncologic outcomes.
Snow-Lisy DC; Campbell SC; Gill IS; Hernandez AV; Fergany A; Kaouk J; Haber GP
Eur Urol; 2014 Jan; 65(1):193-200. PubMed ID: 24018019
[TBL] [Abstract][Full Text] [Related]
3. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB
Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
[TBL] [Abstract][Full Text] [Related]
5. Urothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resection.
Morton E; Kaul S; Fleishman A; Korets R; Chang P; Wagner A; Kim SP; Bellmunt J; Kaplan I; Olumi AF; Gershman B
Urol Oncol; 2023 May; 41(5):255.e7-255.e14. PubMed ID: 36470805
[TBL] [Abstract][Full Text] [Related]
6. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
Koga F; Fujii Y; Masuda H; Numao N; Yokoyama M; Ishioka J; Saito K; Kawakami S; Kihara K
BJU Int; 2012 Sep; 110(6 Pt B):E203-8. PubMed ID: 22289431
[TBL] [Abstract][Full Text] [Related]
7. National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013.
Bateni ZH; Pearce SM; Zainfeld D; Ballas L; Djaladat H; Schuckman AK; Daneshmand S
Eur Urol Oncol; 2020 Jun; 3(3):343-350. PubMed ID: 31317867
[TBL] [Abstract][Full Text] [Related]
8. [Patients with bladder cancer in clinical stage T2 : survival benefit of downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens].
May M; Fritsche HM; Brookman-May S; Burger M; Bolenz C; Trojan L; Herrmann E; Michel MS; Wülfing C; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Gilfrich C; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Gunia S; Bastian PJ
Urologe A; 2010 Dec; 49(12):1508-15. PubMed ID: 20922515
[TBL] [Abstract][Full Text] [Related]
9. Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease.
Tollefson MK; Boorjian SA; Farmer SA; Frank I
World J Urol; 2012 Dec; 30(6):795-9. PubMed ID: 22447397
[TBL] [Abstract][Full Text] [Related]
10. Robot-assisted radical cystectomy: description of an evolved approach to radical cystectomy.
Collins JW; Tyritzis S; Nyberg T; Schumacher M; Laurin O; Khazaeli D; Adding C; Jonsson MN; Hosseini A; Wiklund NP
Eur Urol; 2013 Oct; 64(4):654-63. PubMed ID: 23769588
[TBL] [Abstract][Full Text] [Related]
11. Conditional survival following radical cystectomy for urothelial carcinoma of the bladder.
Moreno MF; Kaul S; Fleishman A; Korets R; Chang P; Wagner A; Kim S; Bellmunt J; Kaplan I; Olumi AF; Gershman B
Urol Oncol; 2023 Oct; 41(10):432.e11-432.e20. PubMed ID: 37500322
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and Prognostic Factors of Patients with Urothelial Carcinoma Undergoing Radical Cystectomy and pT0 in the Final Histology Without Neoadjuvant Chemotherapy.
Rodler S; Buchner A; Eismann L; Schulz GB; Marcon J; Ledderose S; Schlenker B; Stief CG; Karl A; Jokisch JF
Res Rep Urol; 2022; 14():281-290. PubMed ID: 35937307
[TBL] [Abstract][Full Text] [Related]
13. Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results.
Ma B; Li Y; Han S; Jiang X; Zhao Y; Guo J; Quan C; Niu Y
Eur J Surg Oncol; 2019 Oct; 45(10):1993-1999. PubMed ID: 31327502
[TBL] [Abstract][Full Text] [Related]
14. Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.
Yuh B; Wilson T; Bochner B; Chan K; Palou J; Stenzl A; Montorsi F; Thalmann G; Guru K; Catto JW; Wiklund PN; Novara G
Eur Urol; 2015 Mar; 67(3):402-22. PubMed ID: 25560797
[TBL] [Abstract][Full Text] [Related]
15. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ
Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102
[TBL] [Abstract][Full Text] [Related]
16. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
Abdollah F; Sun M; Schmitges J; Djahangirian O; Tian Z; Jeldres C; Perrotte P; Shariat SF; Montorsi F; Karakiewicz PI
BJU Int; 2012 Apr; 109(8):1147-54. PubMed ID: 21883849
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy.
Moschini M; Mattei A; Cornelius J; Shariat SF; Dell'Oglio P; Zaffuto E; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
World J Urol; 2018 Apr; 36(4):639-644. PubMed ID: 29368231
[TBL] [Abstract][Full Text] [Related]
18. The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes.
Moschini M; Shariat SF; Abufaraj M; Soria F; Klatte T; Croce G; Mattei A; Damiano R; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
Urol Oncol; 2017 Apr; 35(4):151.e17-151.e23. PubMed ID: 27932269
[TBL] [Abstract][Full Text] [Related]
19. Role of pelvic lymph node dissection in lymph node-negative patients with invasive bladder cancer.
Shirotake S; Kikuchi E; Matsumoto K; Yazawa S; Kosaka T; Miyajima A; Nakagawa K; Oya M
Jpn J Clin Oncol; 2010 Mar; 40(3):247-51. PubMed ID: 19887521
[TBL] [Abstract][Full Text] [Related]
20. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
